|
US5994618A
(en)
|
1997-02-05 |
1999-11-30 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 transgenic mice
|
|
US7566768B1
(en)
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
|
WO1994021681A1
(en)
|
1993-03-19 |
1994-09-29 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
|
US7393682B1
(en)
*
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
|
US7332575B2
(en)
|
1994-03-18 |
2008-02-19 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
|
|
US6008434A
(en)
|
1994-07-08 |
1999-12-28 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-11 transgenic mice
|
|
GB2333706A
(en)
*
|
1998-02-02 |
1999-08-04 |
Merck & Co Inc |
Method for increasing muscle mass in animals
|
|
US6369201B1
(en)
*
|
1998-02-19 |
2002-04-09 |
Metamorphix International, Inc. |
Myostatin multimers
|
|
WO2000009667A1
(en)
*
|
1998-08-14 |
2000-02-24 |
Board Of Regents, The University Of Texas System |
Calcineurin-dependent control of skeletal muscle fiber type
|
|
CA2359242C
(en)
*
|
1999-01-21 |
2009-12-08 |
Metamorphix, Inc. |
Growth differentiation factor inhibitors and uses therefor
|
|
EE200200025A
(et)
|
1999-07-20 |
2003-04-15 |
Pharmexa A/S |
Meetod GDF-8 aktiivsuse allareguleerimiseks, meetod looma lihasmassi suurendamiseks, GDF-8 analoog,immunogeenne kompositsioon, nukleiinhappefragment, vektor, transformeeritud rakk ja selle valmistamismeetod, kompositsioon GDF-8 vastaste antikehadeto
|
|
EP1072680A1
(en)
*
|
1999-07-30 |
2001-01-31 |
Pfizer Products Inc. |
Myostatin regulatory region, nucleotide sequence determination and methods for its use
|
|
US7011943B2
(en)
|
2000-09-06 |
2006-03-14 |
Transnetyx, Inc. |
Method for detecting a designated genetic sequence in murine genomic DNA
|
|
US7494817B2
(en)
|
2000-09-06 |
2009-02-24 |
Transnet Yx, Inc. |
Methods for genotype screening using magnetic particles
|
|
DE60135357D1
(de)
*
|
2000-09-06 |
2008-09-25 |
Timothy A Hodge |
Verfahren zum Screenen von genomischer DNS, insbesonderer bei transgener und zielgerichteter Mutagenese
|
|
US7037501B2
(en)
|
2001-01-04 |
2006-05-02 |
Regents Of The University Of Minnesota |
Myostatin immnoconjugate
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
ES2359562T3
(es)
*
|
2002-12-20 |
2011-05-24 |
Amgen, Inc. |
Agentes de unión que inhiben miostatina.
|
|
EP1590471A4
(en)
|
2002-12-31 |
2009-12-09 |
Metamorphix Inc |
COMPOSITIONS, METHODS AND SYSTEMS OF INFERENCE RELATING TO CATTLE CHARACTERISTICS
|
|
KR20060026860A
(ko)
|
2003-06-02 |
2006-03-24 |
와이어쓰 |
신경근 장애의 치료를 위한, 코르티코스테로이드와 조합된미오스타틴 (ｇｄｆ８) 저해제의 용도
|
|
ES2852549T3
(es)
*
|
2005-02-09 |
2021-09-13 |
Sarepta Therapeutics Inc |
Composición antisentido para tratamiento de la atrofia muscular
|
|
SI1915397T1
(sl)
|
2005-08-19 |
2015-05-29 |
Wyeth Llc |
Antagonistična protitelesa proti GDF-8 in uporabe pri zdravljenju ALS in drugih obolenj, povezanih z GDF-8
|
|
KR100872042B1
(ko)
*
|
2005-09-14 |
2008-12-05 |
주식회사 바이오리더스 |
마이오스타틴을 발현하는 세포표면 발현벡터 및 상기벡터에 의해 형질전환된 미생물
|
|
GB2433320B
(en)
*
|
2005-12-16 |
2009-10-07 |
Norwegian University Of Life S |
Diagnostic method
|
|
CA2558160C
(en)
*
|
2006-06-30 |
2017-01-03 |
Oligos Etc., Inc. |
Antisense oligonucleotide targeting myostatin or fox01 for treatment of muscle wasting
|
|
KR100857861B1
(ko)
*
|
2007-10-15 |
2008-09-11 |
주식회사 바이오리더스 |
Ｍｙｏ－２ 펩타이드 중합체와 마이오스타틴의 융합단백질표면발현용 벡터 및 상기 벡터로 형질전환된 미생물
|
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
|
US10920242B2
(en)
|
2011-02-25 |
2021-02-16 |
Recombinetics, Inc. |
Non-meiotic allele introgression
|
|
WO2012116274A2
(en)
*
|
2011-02-25 |
2012-08-30 |
Recombinetics, Inc. |
Genetically modified animals and methods for making the same
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
KR101704893B1
(ko)
|
2012-06-15 |
2017-02-08 |
화이자 인코포레이티드 |
Gdf-8에 대한 개선된 길항물질 항체 및 그의 용도
|
|
AR091482A1
(es)
*
|
2012-06-21 |
2015-02-04 |
Recombinetics Inc |
Celulas modificadas geneticamente y metodos par su obtencion
|
|
PL2981822T3
(pl)
|
2013-05-06 |
2021-07-12 |
Scholar Rock, Inc. |
Kompozycje i sposoby modulacji czynnika wzrostu
|
|
EP2960653A1
(en)
*
|
2014-06-24 |
2015-12-30 |
Stichting Kwaliteitsgarantie Vleeskalversector |
Diagnostic kit and method for the identification of the manipulation of muscle mass in a domestic animal
|
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
|
WO2017062835A2
(en)
*
|
2015-10-09 |
2017-04-13 |
Sarepta Therapeutics, Inc. |
Compositions and methods for treating duchenne muscular dystrophy and related disorders
|
|
CN106472430A
(zh)
*
|
2016-10-21 |
2017-03-08 |
延边朝鲜族自治州农业科学院（延边特产研究所） |
一种寒冷地区烟蚜茧蜂冬季保种方法
|
|
WO2019174560A1
(zh)
*
|
2018-03-14 |
2019-09-19 |
必康生技（香港）有限公司 |
用于生物流体净化的组合物
|
|
CN110157818B
(zh)
*
|
2019-07-08 |
2023-04-25 |
云南东恒经贸集团猪育种有限公司 |
一种与猪眼肌高产性状相关的分子标记及其应用
|
|
KR20230130639A
(ko)
*
|
2020-12-03 |
2023-09-12 |
(주)라트바이오 |
마이오스타틴 유전자가 변형된 형질전환 동물
|
|
CN120192396A
(zh)
*
|
2023-12-21 |
2025-06-24 |
江苏省农业科学院 |
一种肌肉生长抑制素mstn蛋白突变体及其制备方法和应用
|